MATTHEW FRANKLIN: Open Payments
NPI 1033843909 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 12 payments from 8 companies in 2025. Trend: 2023 $82 · 2024 $559 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Ethicon US, LLC | 1 | $115 |
| Daiichi Sankyo Inc. | 4 | $93 |
| PFIZER INC. | 1 | $62 |
| Genentech USA, Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $19 |
| Legend Biotech USA Inc. | 1 | $17 |
Products named: STRATAFIX, Vanflyta, ELREXFIO, TECVAYLI, Venclexta, NIKTIMVO, CARVYKTI.
Industry payments across DE — which companies pay providers there.
